Changes
Click [[Gastrointestinal Endoscopy - Market and Volume analysis| here]] to go back to main page.
<br>
{|border="0" cellspacing="0" cellpadding="4" width="80%" align="center"
|
|
|
|
|-
|
|bgcolor = "#376091" colspan = "2"|<font color="#FFFFFF">'''Boston Scientific'''</font>
|
|-
|
|bgcolor = "#C5D9F1"|'''Brief Description'''
|bgcolor = "#C5D9F1"|They make medical supplies and devices used to diagnose and treat conditions in a variety of medical fields, with an emphasis on cardiovascular products and cardiac rhythm management. It also makes devices used for gynecology and urology, endoscopy, and pain management (neuromodulation). Its 13,000-plus products, made in a dozen factories worldwide, include defibrillators, catheters, coronary and urethral stents, pacemakers, biopsy forceps and needles, and urethral slings. Boston Scientific markets its wares in more than 100 countries, primarily through its own direct sales staff.
|
|-
|
|rowspan = "3"|'''Revenues'''
|2008: 8.05 billion USD
|
|-
|
|2009: 8.19 billion USD
|
|-
|
|2010: 7.81 billion USD
|
|-
|
|bgcolor = "#C5D9F1"|'''Net profit (2010)'''
|bgcolor = "#C5D9F1"| (1.07) billion USD
|
|-
|
|rowspan = "3"|'''R&D expenses'''
|2008: 1.006 billion USD (12.6% of revenues)
|
|-
|
|2009: 1.035 billion USD (12.5% of revenues)
|
|-
|
|2010: 0.939 billion USD (12.0% of revenues)
|
|-
|
|bgcolor = "#C5D9F1"|'''Number of employees'''
|bgcolor = "#C5D9F1"|25,000
|
|-
|
|'''Year Established'''
|1979
|
|-
|
|bgcolor = "#C5D9F1"|'''Headquarters'''
|bgcolor = "#C5D9F1"|1 Boston Scientific Place Natick, MA 01760-1537, United States
|
|-
|
|'''Key People'''
|J. Raymond Elliott (CEO)<br>Peter Nicholas (Chairman)
|
|-
|
|bgcolor = "#C5D9F1"|'''Segmental revenue breakdown (2010)'''
|bgcolor = "#C5D9F1"|Cardiovascular group: 42%<br>Cardiac rhythm management: 28%<br>Endoscopy: 14%<br>Urology/Women's Health: 6%<br>Others: 10%
|
|-
|
|'''Geographical revenue breakdown (2010)'''
|US: 56%%<br>EMEA: 23%<br>Rest of world: 21%
|
|-
|}<br clear="all">
<br>
{|border="0" cellspacing="0" cellpadding="4" width="80%" align="center"
|
|
|
|
|-
|
|bgcolor = "#376091" colspan = "2"|<font color="#FFFFFF">'''Boston Scientific'''</font>
|
|-
|
|bgcolor = "#C5D9F1"|'''Brief Description'''
|bgcolor = "#C5D9F1"|They make medical supplies and devices used to diagnose and treat conditions in a variety of medical fields, with an emphasis on cardiovascular products and cardiac rhythm management. It also makes devices used for gynecology and urology, endoscopy, and pain management (neuromodulation). Its 13,000-plus products, made in a dozen factories worldwide, include defibrillators, catheters, coronary and urethral stents, pacemakers, biopsy forceps and needles, and urethral slings. Boston Scientific markets its wares in more than 100 countries, primarily through its own direct sales staff.
|
|-
|
|rowspan = "3"|'''Revenues'''
|2008: 8.05 billion USD
|
|-
|
|2009: 8.19 billion USD
|
|-
|
|2010: 7.81 billion USD
|
|-
|
|bgcolor = "#C5D9F1"|'''Net profit (2010)'''
|bgcolor = "#C5D9F1"| (1.07) billion USD
|
|-
|
|rowspan = "3"|'''R&D expenses'''
|2008: 1.006 billion USD (12.6% of revenues)
|
|-
|
|2009: 1.035 billion USD (12.5% of revenues)
|
|-
|
|2010: 0.939 billion USD (12.0% of revenues)
|
|-
|
|bgcolor = "#C5D9F1"|'''Number of employees'''
|bgcolor = "#C5D9F1"|25,000
|
|-
|
|'''Year Established'''
|1979
|
|-
|
|bgcolor = "#C5D9F1"|'''Headquarters'''
|bgcolor = "#C5D9F1"|1 Boston Scientific Place Natick, MA 01760-1537, United States
|
|-
|
|'''Key People'''
|J. Raymond Elliott (CEO)<br>Peter Nicholas (Chairman)
|
|-
|
|bgcolor = "#C5D9F1"|'''Segmental revenue breakdown (2010)'''
|bgcolor = "#C5D9F1"|Cardiovascular group: 42%<br>Cardiac rhythm management: 28%<br>Endoscopy: 14%<br>Urology/Women's Health: 6%<br>Others: 10%
|
|-
|
|'''Geographical revenue breakdown (2010)'''
|US: 56%%<br>EMEA: 23%<br>Rest of world: 21%
|
|-
|}<br clear="all">
